New approaches to the pharmacological treatment of angina

Autor:	Robert S. Schwartz, Antonio Bayes-Genis, Ali E. Denktas
Rok vydání:	2001
Předmět:	Ticlopidine Angiotensin-Converting Enzyme Inhibitors Platelet Glycoprotein GPIIb-IIIa Complex Pharmacology Bioinformatics Pharmacological treatment Adrenergic beta-Antagonists Angina Pectoris Angina Fibrinolytic Agents Drug Discovery Medicine Humans Thrombolytic Therapy Angina Unstable Angioplasty Balloon Coronary Clinical Trials as Topic Aspirin business.industry Unstable angina Heparin Thrombin medicine.disease Calcium Channel Blockers Platelet aggregation inhibitor Drug Therapy Combination business Fibrinolytic agent Platelet Aggregation Inhibitors Discovery and development of direct thrombin inhibitors medicine.drug
Zdroj:	Current opinion in pharmacology. 1(2)
ISSN:	1471-4892
Popis:	The treatment of angina is changing, with many new agents being added to those existing agents that have been used for many years. New data regarding the use of glycoprotein IIb/IIIa inhibitors now exist and low molecular weight heparins are used more frequently with greater efficacy than unfractionated heparin. New thrombin inhibitors are also receiving a fresh look. An expert panel has recently published guidelines for the treatment of unstable angina.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68849137daec346faf95324d59f57750 https://pubmed.ncbi.nlm.nih.gov/11714089 Zobrazit plný text záznamu Full Text from ScienceDirect